This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Dynamic change of MMP-1/TIMP-1 expression in experimental immune hepatic fibrosis
Zhi-Jun Duan, Xiang Hu, Zhi-Hong Gao, Chen Tan, Hong Yuan, Shi-Jun Li
Zhi-Jun Duan, Zhi-Hong Gao, Chen Tan, Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
Xiang Hu, Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
Hong Yuan, Shi-Jun Li, Testing Center, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
Correspondence to: Zhi-Jun Duan, Department of Gastroenterology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China. firstname.lastname@example.org
Received: February 28, 2005 Revised: March 11, 2005 Accepted: March 22, 2005 Published online: May 1, 2005
AIM: To evaluate the roles of matrix metalloproteinase-1/ tissue inhibitor of metalloproteinse-1 (MMP-1/TIMP-1) in the course of formation and progression of liver fibrosis.
METHODS: Forty-eight female SD rats, 120-150 g in weight, were divided randomly into 2 groups, 8 rats in normal control group and 40 rats in fibrosis group. The fibrotic animal model was established according to the method of Blackwell with some modifications. Human serum albumin (HSA)-sensitized rats were further attacked by i. v. injection of HSA through the coccygeal vein. Liver tissues were obtained 0, 2, 4, 6, and 8 weeks after the attack. Liver hydroxyproline (HYP) content was determined, and HE, argentophilic as well as Van Gieson's (VG) stainings were performed to monitor the process of fibroproliferation. The protein and RNA of MMP-1/TIMP-1 were analyzed using ELISA and semi-quantitative RT-PCR, respectively.
RESULTS: Gradual formation of hepatic fibrosis was detected in the rats, which indicated an ideal model to study the process of generation and development of fibrosis. MMP-1 protein was present in the normal liver, with no significant change in fibrosis and cirrhosis (P>0.05). In contrast, TIMP-1 protein was increased progressively (P<0.01, after 4 weeks), reaching the peak in the stage of cirrhosis (the value after 8 wks was increased by 4 folds). In consistence with the changes of the proteins, MMP-1 mRNA expression did not alter significantly during the fibrosis process (P>0.05), while TIMP-1 mRNA expression was increased gradually (P<0.01, after 4 weeks). MMP-1/TIMP-1 ratio tended to decrease in this process. The change was more profound after 4 weeks (P<0.01). Moreover, the extent of the increase of TIMP-1 and the decrease of MMP-1/TIMP-1 ratio was well correlated with the extent of fibrosis, as revealed by the study of rats in different groups with different grades of fibroproliferation.
CONCLUSION: The main cause responsible for the deposition of extracellular matrix (ECM) during fibrosis might not be a gradual decrease in MMP-1 level, but a progressing increase in TIMP-1 level, which suppresses the activity of MMP-1 so as to diminish matrix degradation. A gradual decrease of MMP-1/TIMP-1 ratio during this process indicates a progressing disproportion between MMP-1 and TIMP-1, which accelerates the fibrosis process. TIMP-1 expression and MMP-1/TIMP-1 ratio are two useful indexes to reflect the fibrotic extent.
Nie QH, Cheng YQ, Xie YM, Zhou YX, Cao YZ. Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.World J Gastroenterol. 2001;7:363-369.
Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M, Sugimachi K. Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor b-1.J Gastroenterol Hepatol. 2002;17:59-65.
Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S, Sato H, Seiki M, Watanabe A. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human liver.Hepatology. 1997;26:1521-1529.
Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabro A, Ciancio G, Stefanini F. Differential expression of matrix-metalloproteinase-1 and 2 genes in normal and fibrotic human liver.Am J Pathol. 1994;144:528-537.
Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinase 1 and 2 is increased in fibrotic human liver.Gastroenterology. 1996;110:821-831.
Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.J Biol Chem. 1991;266:14064-14071.
Roeb E, Graeve L, Hoffmann R, Decker K, Edwards DR, Heinrich PC. Regulation of tissue inhibitor of metallo proteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures.Hepatology. 1993;18:1437-1442.
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.Eur J Cell Biol. 1997;74:111-122.
Kordula T, Guttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interlukin-6 and transforming growth factor beta1.Febs Lett. 1992;313:144-147.
Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.J Clin Invest. 1998;102:538-549.
Arthur M J, Mann DA, Iredale JP. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.J Gastroenterol Hepatol. 1998;13:S33-38.
Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJ. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes.Clin Sci (Lond). 1995;89:75-81.
Lichtinghagen R, Huegel O, Seifert T, Haberkorn CI, Michels D, Flemming P, Bahr M, Boeker KH. Expression of matrix metalloproteinase-2 and 9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.Clin Chem. 2000;46:183-192.
Holoman J, Glasa J, Galbavy S, Danis D, Molnarova A, Kazar J, Bednarova A, Misianik J. Serum markers of liver fibrogenesis, and liver histology findings in patients with chronic liver diseases.Bratisl Lek Listy. 2002;103:70-75.
Boeker KH, Haberkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.Clin Chim Acta. 2002;316:71-81.
Murawaki Y, Ikuta Y, Kawasaki H. Clinical usefulness of serum tissue inhibitor of metalloproteinases(TIMP-2)assay in patients with chronic liver disease in comparison with serum TIMP-1.Clin Chim Acta. 1999;281:109-120.
Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH. Diagnosis value of platelet deriverd growth factor-BB, transforming growth factor-betal, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.World J Gastroenterol. 2003;9:2490-2496.
Flisiak R, Al-Kadasi H, Jaroszewicz J, Prokopowicz D, Flisiak I. Effect of lamivudine treatment on plasma levels of transforming growth factor betal, tissue inhibitor of metalloproteinses-1 and metalloproteinase-1 in patients with chronic hepatitis B.World J Gastroenterol. 2004;10:2661-2665.
Cai WM, Zhang BB, Weng HL, Hu ZR, Lv J, Zheng M, Liu RH. The diagnosis value of eight serum indices for liver fibrosis.Zhonghua Ganzangbing Zazhi. 2004;12:219-222.
Luo YJ, Yu JP, Shi ZH, Wang L. Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.World J Gastroenterol. 2004;10:1037-1042.